WuXi XDC faced significant shareholder sell-off, with the stock price dropping nearly 7% at one point
I'm PortAI, I can summarize articles.
WuXi XDC (2268) shareholder Huanquan Pharmaceutical Hong Kong Investment Co., Ltd. significantly reduced its holdings by 50.8 million shares, involving an investment of HKD 2.178 billion, at a price of HKD 42.88 per share, a discount of 6.78% compared to the previous closing price. Affected by this news, WuXi XDC's stock price once fell nearly 7%, reaching a low of HKD 42.85, currently reported at HKD 44.5, a decline of 3.3%. Its related companies, WuXi AppTec (2359) and WuXi Biologics (2269), fell by 0.4% and 0.3%, respectively
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Stheadline The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments